Bicyclic compound, production and use thereof
AssigneeTobira Therapeutics, Inc.
InventorsMitsuru Shiraishi, Masanori Baba, Katsuji Aikawa, Naoyuki Kanzaki, Masaki Seto, Yuji Iizawa
Life of this patent
Estimating the term…
Loading patent…
AssigneeTobira Therapeutics, Inc.
InventorsMitsuru Shiraishi, Masanori Baba, Katsuji Aikawa, Naoyuki Kanzaki, Masaki Seto, Yuji Iizawa
Estimating the term…
The present invention provides a new cyclic compound having a CCR antagonist activity, especially a CCR5 antagonist activity, and the use thereof. The compound of the present invention is represented by the formula: wherein, R1 is a 5- to 6-membered ring group which may be substituted; X1 is a bond or the like; ring A is a 5- to 6-membered ring group which may be substituted; ring B is a 8- to 10-membered ring group which may be substituted; X2 is a bivalent group of 1 to 4 atom; Z1 is a bivalent cyclic ring group or the like; Z2 is a bond or the like; and R2 is an amino group, a nitrogen-containing heterocyclic group which may be substituted or the like, or a salt thereof.
A method for treating cancer which comprises administering an effective amount of a compound of Formula I,
A method for treating cancer which comprises administering an effective amount of a compound of Formula (II):
Dependencies are inferred from the claim text.